Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2013 1
2014 1
2016 2
2017 1
2018 1
2019 4
2020 1
2021 2
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Targeting Bruton Tyrosine Kinase.
Brunner C, Betzler AC, Brown JR, Andreotti AH, Grassilli E. Brunner C, et al. Among authors: grassilli e. Front Cell Dev Biol. 2022 Apr 26;10:909655. doi: 10.3389/fcell.2022.909655. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35557950 Free PMC article. No abstract available.
Identifying Novel Actionable Targets in Colon Cancer.
Cerrito MG, Grassilli E. Cerrito MG, et al. Among authors: grassilli e. Biomedicines. 2021 May 20;9(5):579. doi: 10.3390/biomedicines9050579. Biomedicines. 2021. PMID: 34065438 Free PMC article. Review.
BTK, the new kid on the (oncology) block?
Grassilli E, Cerrito MG, Lavitrano M. Grassilli E, et al. Front Oncol. 2022 Aug 4;12:944538. doi: 10.3389/fonc.2022.944538. eCollection 2022. Front Oncol. 2022. PMID: 35992808 Free PMC article. Review.
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors.
Grassilli E, Cerrito MG, Bonomo S, Giovannoni R, Conconi D, Lavitrano M. Grassilli E, et al. Front Cell Dev Biol. 2021 Jun 7;9:690365. doi: 10.3389/fcell.2021.690365. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34164404 Free PMC article. Review.
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers.
Lavitrano M, Ianzano L, Bonomo S, Cialdella A, Cerrito MG, Pisano F, Missaglia C, Giovannoni R, Romano G, McLean CM, Voest EE, D'Amato F, Noli B, Ferri GL, Agostini M, Pucciarelli S, Helin K, Leone BE, Canzonieri V, Grassilli E. Lavitrano M, et al. Among authors: grassilli e. J Pathol. 2020 Feb;250(2):134-147. doi: 10.1002/path.5347. Epub 2019 Dec 2. J Pathol. 2020. PMID: 31518438
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer.
Basile D, Gerratana L, Buonadonna A, Garattini SK, Perin T, Grassilli E, Miolo G, Cerrito MG, Belluco C, Bertola G, De Paoli A, Cannizzaro R, Lavitrano M, Puglisi F, Canzonieri V. Basile D, et al. Among authors: grassilli e. Cancers (Basel). 2019 Jun 24;11(6):880. doi: 10.3390/cancers11060880. Cancers (Basel). 2019. PMID: 31238520 Free PMC article.
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma.
Giordano F, Vaira V, Cortinovis D, Bonomo S, Goedmakers J, Brena F, Cialdella A, Ianzano L, Forno I, Cerrito MG, Giovannoni R, Ferri GL, Tasciotti E, Vicent S, Damarco F, Bosari S, Lavitrano M, Grassilli E. Giordano F, et al. Among authors: grassilli e. J Exp Clin Cancer Res. 2019 Jun 14;38(1):260. doi: 10.1186/s13046-019-1199-7. J Exp Clin Cancer Res. 2019. PMID: 31200752 Free PMC article.
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation.
Scagliotti A, Capizzi L, Cazzaniga ME, Ilari A, De Giorgi M, Cordani N, Gallazzi M, Bruno A, Pelosi G, Albini A, Lavitrano M, Grassilli E, Cerrito MG. Scagliotti A, et al. Among authors: grassilli e. Front Oncol. 2022 Nov 30;12:998274. doi: 10.3389/fonc.2022.998274. eCollection 2022. Front Oncol. 2022. PMID: 36531071 Free PMC article.
21 results